You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美團買藥啟動空運等四舉措 為呼吸道感染熱門藥保供應
阿思達克 12-07 16:56
內媒報道,美團買藥相關負責人介紹,考慮到近期速福達、希舒美、達菲、可威等呼吸道感染相關用藥需求持續增加,美團自營大藥房已啟動順豐空運達、現貨極速發、品牌保正品、平台控穩價等四項措施,與相關藥企深度密切合作,全力保障呼吸道感染高需品平價供應。 美團買藥健康指數顯示,進入12月以來,甲流相關用藥在華北、華東及中西部地區的需求依然很高。其中,奧司他韋的訂單量在華東和中西部地區起跳幅度最高,速福達在西安地區的訂單量增長接近兩倍。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account